Ana GrafGlobal Program Head at Novartis
Dr. Ana Graf is Global Program Head in Novartis Neuroscience Global Drug Development. In that role, she leads the teams responsible for global development of drug candidates for treatment of neurological diseases.
Over 30 years at Novartis, she was involved in all phases of drug development across a range of indications and therapeutic modalities. Her main focus is on early development in neurodegeneration. Dr.Graf is now overseeing development strategies for early neuroscience portfolio, in close collaboration with Novartis Institutes for Biomedical Research and Business Development and Licensing.
Dr. Graf holds M.D. degree from Universities of Zagreb, Croatia and Zurich, Switzerland. She is based in Basel, Switzerland.
Novartis in neuroscience – translating strategy into science and partnering, 14:30View Session